October 2014
Ancor Capital announced the sale of the Prescription Pharmaceutical Business of WellSpring Pharmaceutical Corporation. “The sale of the business allows WellSpring to focus on its core competency of OTC products and contract manufacturing of pharmaceuticals” said Wendy Shusko, President of WellSpring Pharmaceutical. “Additionally, the strong capital base provided by this transaction and our investors will...
Read More